Background:Interleukin 13 receptor subunit alpha 2(IL13RA2)plays an essential role in the progression of many cancers.However,the role of IL13RA2 in infantile haemangioma(IH)is still unknown.Materials and Methods:IL13...Background:Interleukin 13 receptor subunit alpha 2(IL13RA2)plays an essential role in the progression of many cancers.However,the role of IL13RA2 in infantile haemangioma(IH)is still unknown.Materials and Methods:IL13RA2 expression in IH tissues was analyzed using western blot,qRT-PCR,and immunofluorescence.The role of IL13RA2 in haemangioma-derived endothelial cells(HemECs)was determined following knockdown or overexpression of IL13RA2 using CCK-8,colony formation,apoptosis,wound healing,tubule formation,Transwell,and western blot.Results:IL13RA2 expression was upregulated in IH tissues.IL13RA2 overexpression promoted proliferation,migration,and invasion of HemECs and induced glycolysis,which was confirmed with a glycolysis inhibitor.Specifically,IL13RA2 interacted withβ-catenin and activated the Wnt/β-catenin pathway in HemECs,which were involved in the above-mentioned effects of IL13RA2.Conclusions:These findings revealed that targeting IL13RA2 is a potential therapeutic approach for IH.展开更多
目的探讨IL18RAP基因与肝癌患者预后和肿瘤微环境中CD8^(+)T细胞浸润的相关性以及作为肿瘤标志物的可能性。方法癌症基因组图谱(The Cancer Genome Atlas,TCGA)用于评估IL18RAP基因在肝癌中的表达。单因素Cox分析、多因素COX分析和生存...目的探讨IL18RAP基因与肝癌患者预后和肿瘤微环境中CD8^(+)T细胞浸润的相关性以及作为肿瘤标志物的可能性。方法癌症基因组图谱(The Cancer Genome Atlas,TCGA)用于评估IL18RAP基因在肝癌中的表达。单因素Cox分析、多因素COX分析和生存分析揭示IL18RAP基因的预后价值。KEGG、GO和Hallmark富集分析寻找与IL18RAP基因相关的功能通路。免疫浸润分析探究IL18RAP基因与22种免疫细胞浸润的关系。通过单细胞测序数据库与免疫组化验证IL18RAP基因与CD8^(+)T细胞浸润的相关性。结果IL18RAP在肝癌组织中表达下调,其低表达与肝癌患者的不良预后相关。功能富集分析显示IL18RAP的表达与免疫功能通路相关。免疫浸润、单细胞测序和免疫组化表明IL18RAP高表达于CD8^(+)T细胞。结论IL18RAP低表达与肝癌患者的不良预后相关,可能影响了抗肿瘤免疫的CD8^(+)T细胞。展开更多
文摘Background:Interleukin 13 receptor subunit alpha 2(IL13RA2)plays an essential role in the progression of many cancers.However,the role of IL13RA2 in infantile haemangioma(IH)is still unknown.Materials and Methods:IL13RA2 expression in IH tissues was analyzed using western blot,qRT-PCR,and immunofluorescence.The role of IL13RA2 in haemangioma-derived endothelial cells(HemECs)was determined following knockdown or overexpression of IL13RA2 using CCK-8,colony formation,apoptosis,wound healing,tubule formation,Transwell,and western blot.Results:IL13RA2 expression was upregulated in IH tissues.IL13RA2 overexpression promoted proliferation,migration,and invasion of HemECs and induced glycolysis,which was confirmed with a glycolysis inhibitor.Specifically,IL13RA2 interacted withβ-catenin and activated the Wnt/β-catenin pathway in HemECs,which were involved in the above-mentioned effects of IL13RA2.Conclusions:These findings revealed that targeting IL13RA2 is a potential therapeutic approach for IH.
文摘目的探讨IL18RAP基因与肝癌患者预后和肿瘤微环境中CD8^(+)T细胞浸润的相关性以及作为肿瘤标志物的可能性。方法癌症基因组图谱(The Cancer Genome Atlas,TCGA)用于评估IL18RAP基因在肝癌中的表达。单因素Cox分析、多因素COX分析和生存分析揭示IL18RAP基因的预后价值。KEGG、GO和Hallmark富集分析寻找与IL18RAP基因相关的功能通路。免疫浸润分析探究IL18RAP基因与22种免疫细胞浸润的关系。通过单细胞测序数据库与免疫组化验证IL18RAP基因与CD8^(+)T细胞浸润的相关性。结果IL18RAP在肝癌组织中表达下调,其低表达与肝癌患者的不良预后相关。功能富集分析显示IL18RAP的表达与免疫功能通路相关。免疫浸润、单细胞测序和免疫组化表明IL18RAP高表达于CD8^(+)T细胞。结论IL18RAP低表达与肝癌患者的不良预后相关,可能影响了抗肿瘤免疫的CD8^(+)T细胞。